Abstract 2475: MB5029: A novel anti-PD-1 x IL-2v with improved safety profile and enhanced anti-tumor efficacy by selectively targeting activated T cells
Park, Bom, Bang, Hyojoo, Kim, So Woon, Kim, Suna, Cho, Sunjung, Kim, Suyoon, Kim, Minwoo, Park, Youngjin, Park, Jun-Eui
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Get full text
Journal Article
인터류킨-2 융합단백질, 이의 제조방법 및 이를 포함하는 약학 조성물
KANG JIAN, PARK HEUNGROK, LEE KWANGHYUN, PARK SOOBONG, BAE DONGGOO, YOON SORAH, KIM MYEONGBIN, CHOI EUNJU, RYU SEONG EON, KIM SO HEE, KIM SUYOON
Year of Publication 31.07.2024
Get full text
Year of Publication 31.07.2024
Patent
INTERLEUKIN-2 FUSION PROTEIN, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME
PARK, Soobong, KIM, Myeongbin, PARK, Heungrok, KIM, Suyoon, BAE, Donggoo, KIM, So Hee, CHOI, Eunju, YOON, Sorah, LEE, Kwanghyun, RYU, Seong Eon, KANG, Jian
Year of Publication 29.06.2023
Get full text
Year of Publication 29.06.2023
Patent